Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults
Status:
Completed
Trial end date:
2019-10-22
Target enrollment:
Participant gender:
Summary
The Primary objectives of this study are to evaluate the safety and tolerability of ZSP1603
and the Secondary objective is to estimate the pharmacokinetic (PK) parameters after orally
administered once daily of ZSP1603.